Moubin Lin

461 total citations
18 papers, 316 citations indexed

About

Moubin Lin is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Moubin Lin has authored 18 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Moubin Lin's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Moubin Lin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Moubin Lin collaborates with scholars based in China, Germany and United States. Moubin Lin's co-authors include Huaguang Li, Erjiang Tang, Huihong Jiang, Lu Yin, Yun Zhao, Qing Wei, Chenyu Pan, Zhaocai Zhou, Ernest T. Hawk and Wenjing Yang and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Moubin Lin

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moubin Lin China 10 135 118 109 60 50 18 316
Shuoer Wang China 10 159 1.2× 129 1.1× 124 1.1× 29 0.5× 54 1.1× 16 323
Yasunobu Mano Japan 11 213 1.6× 99 0.8× 172 1.6× 50 0.8× 50 1.0× 17 399
Yasuyuki Kanke Japan 10 124 0.9× 56 0.5× 141 1.3× 75 1.3× 36 0.7× 24 288
Fenggang Hou China 12 142 1.1× 113 1.0× 142 1.3× 26 0.4× 38 0.8× 23 313
Ifra Mushtaq India 4 133 1.0× 68 0.6× 88 0.8× 46 0.8× 24 0.5× 6 267
Cheng Fang China 10 204 1.5× 93 0.8× 89 0.8× 38 0.6× 38 0.8× 25 340
Binbin Cui China 12 197 1.5× 123 1.0× 87 0.8× 28 0.5× 26 0.5× 20 340
Liqiang Wang China 11 154 1.1× 145 1.2× 192 1.8× 83 1.4× 63 1.3× 19 402
Hugh Gao Australia 11 156 1.2× 120 1.0× 105 1.0× 86 1.4× 42 0.8× 16 339
Hangying Qu China 9 168 1.2× 144 1.2× 97 0.9× 56 0.9× 27 0.5× 11 314

Countries citing papers authored by Moubin Lin

Since Specialization
Citations

This map shows the geographic impact of Moubin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moubin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moubin Lin more than expected).

Fields of papers citing papers by Moubin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moubin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moubin Lin. The network helps show where Moubin Lin may publish in the future.

Co-authorship network of co-authors of Moubin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Moubin Lin. A scholar is included among the top collaborators of Moubin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moubin Lin. Moubin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chen, Ran, Haoran Qian, Xinyu Xie, et al.. (2025). Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression. Cancer Research. 85(7). 1253–1269. 2 indexed citations
2.
Lin, Moubin, Bin Xing, Hongmiao Wang, et al.. (2025). Citrulline regulates macrophage metabolism and inflammation to counter aging in mice. Science Advances. 11(10). eads4957–eads4957. 9 indexed citations
3.
Yang, Xiaoyi, Rujiao Liu, Juan Jin, et al.. (2025). Cancer stem cells-derived exosomal TSPAN8 enhances non-stem cancer cells stemness and promotes malignant progression in PDAC. Oncogene. 44(27). 2328–2341. 1 indexed citations
4.
Wang, Hui, et al.. (2024). Blocking the E2F transcription factor 1/high-mobility group box 2 pathway enhances the intervention effects of α-santalol on the malignant behaviors of liver cancer cells. The International Journal of Biochemistry & Cell Biology. 168. 106516–106516. 2 indexed citations
5.
Ji, Weidan, Wenchao Wang, Lei Chen, et al.. (2023). Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma. Frontiers in Genetics. 14. 1265866–1265866. 6 indexed citations
6.
Wang, Hui, et al.. (2023). Endoplasmic reticulum stress inhibitor may substitute for sleeve gastrectomy to alleviate metabolic dysfunction-associated steatotic liver disease. Clinics and Research in Hepatology and Gastroenterology. 47(10). 102229–102229. 1 indexed citations
7.
Zhang, Yuan, Huihong Jiang, Zhenyu Wang, Bo Zhai, & Moubin Lin. (2022). Alcohol dehydrogenase 4 is a TP53‑associated gene signature for the prediction of prognosis in hepatocellular carcinoma. Oncology Letters. 25(1). 3–3. 6 indexed citations
9.
10.
Jiang, Huihong, Zhiyong Zhang, Xiaoyan Wang, et al.. (2019). Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations. World Journal of Gastroenterology. 25(20). 2489–2502. 33 indexed citations
11.
Li, Huaguang, Erjiang Tang, Wei Wu, et al.. (2018). PIK3CAandTP53mutations predict overall survival of stage II/III colorectal cancer patients. World Journal of Gastroenterology. 24(5). 631–640. 19 indexed citations
12.
Zhou, Guangxi, Yang Song, Wenjing Yang, et al.. (2017). CD177+ neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer. Carcinogenesis. 39(2). 272–282. 62 indexed citations
13.
Jiang, Huihong, Erjiang Tang, Dan Xu, et al.. (2017). Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer. Oncotarget. 8(18). 29857–29864. 13 indexed citations
14.
Jiang, Huihong, Erjiang Tang, Dan Xu, et al.. (2016). Prognostic Value of the Combination of Preoperative Hemoglobin, Lymphocyte, Albumin, and Neutrophil in Patients with Locally Advanced Colorectal Cancer. Medical Science Monitor. 22. 4986–4991. 11 indexed citations
15.
Chen, Hui, Moubin Lin, Erjiang Tang, et al.. (2015). PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin.. PubMed. 8(1). 1137–43. 14 indexed citations
16.
Lin, Moubin, Yajie Zhang, Erjiang Tang, et al.. (2015). High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin. Oncotarget. 6(18). 16774–16785. 10 indexed citations
17.
Lin, Moubin, Jian Gu, Cathy Eng, et al.. (2012). Genetic Polymorphisms in MicroRNA-Related Genes as Predictors of Clinical Outcomes in Colorectal Adenocarcinoma Patients. Clinical Cancer Research. 18(14). 3982–3991. 56 indexed citations
18.
Lin, Moubin, Haobo Zhang, Yonggang He, et al.. (2011). Serum Biomarkers of Colorectal Cancer with AU and NP20 Chips Including a Diagnosis Model. Hepatogastroenterology. 59(113). 124–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026